XML 39 R26.htm IDEA: XBRL DOCUMENT v3.22.1
ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 15, 2021
USD ($)
Apr. 14, 2020
USD ($)
Feb. 05, 2020
shares
Jun. 30, 2021
USD ($)
Sep. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2021
USD ($)
segment
subsidiary
shares
Dec. 31, 2020
USD ($)
shares
Mar. 26, 2021
USD ($)
Feb. 26, 2021
USD ($)
Oct. 31, 2020
USD ($)
Jun. 15, 2020
shares
Jun. 14, 2020
shares
Feb. 04, 2020
shares
Class of Stock [Line Items]                                
Number of wholly-owned subsidiaries formed | subsidiary                 2              
Number of operating segments | segment                 1              
Number of reportable segments | segment                 1              
Reverse stock split ratio     0.1                          
Common stock, authorized (in shares) | shares     40,000,000         80,000,000 80,000,000 80,000,000       80,000,000 40,000,000 200,000,000
Accumulated deficit               $ (540,747) $ (550,452) $ (540,747)            
Operating lease right-of-use assets               645 0 645            
Property and equipment, net               189 12 189            
Depreciation expense                 100 1,500            
Accrued clinical research costs               1,562 $ 479 1,562            
Scenario, Adjustment                                
Class of Stock [Line Items]                                
Accrued clinical research costs               1,500   1,500            
Accrued manufacturing costs and accrued professional fees, current               100   100            
Minimum                                
Class of Stock [Line Items]                                
Estimated useful lives                 3 years              
Maximum                                
Class of Stock [Line Items]                                
Estimated useful lives                 5 years              
Lab equipment                                
Class of Stock [Line Items]                                
Estimated useful lives                 5 years              
2130 W. Holcombe Blvd. Assets                                
Class of Stock [Line Items]                                
Cash proceeds subject to escrow provisions   $ 1,500                            
R&D Facility | Disposal Group, Held-for-sale, Not Discontinued Operations                                
Class of Stock [Line Items]                                
Operating lease right-of-use assets               500   500     $ 500      
Property and equipment, net               2,300   2,300     2,300      
Lease liability               700   700     $ 700      
Accretion of lease liability               $ 1,300   $ 1,300            
Reed Road, Houston, TX                                
Class of Stock [Line Items]                                
Amount paid upon closing of asset sale                       $ 1,100        
Lease exit agreement, cash receivable                       900        
Lease exit agreement, note receivable                       $ 200        
San Francisco Office Space                                
Class of Stock [Line Items]                                
Operating lease right-of-use assets                     $ 600          
Lease liability                     1,000          
Lease termination fee $ 900                              
Security deposits refund $ 200     $ 200                        
Loss on termination of lease             $ 500   $ 500              
San Francisco Office Space | Lab equipment                                
Class of Stock [Line Items]                                
Operating lease right-of-use assets                     $ 100          
MD Anderson                                
Class of Stock [Line Items]                                
Upfront payment received         $ 5,000                      
Takeda                                
Class of Stock [Line Items]                                
Additional revenue from sales           $ 700